CNSI Cambridge Neuroscience Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CNSI Cambridge Neuroscience

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Mike McFarland who wrote (662)	5/20/2002 9:26:43 AM
From: nigel bates	Read Replies (1) of 675

CeNeS Comments on Press Speculation Regarding the Future of Company Cambridge, UK, 20th May 2002 - CeNeS Pharmaceuticals plc (London: CEN.L - news) (LSE: CEN) today noted press speculation regarding the future of the Company and noted that it was considering a number of options. These options include the possible merger or sale of the Company. Neil Clark, Chief Operating Officer and Financial Director commented; "CeNeS has received no formal approaches. Under our restructuring plan we are reviewing several alternative strategies going forward. The Board is committed to delivering value for shareholders and a secure future for our employees". 20th May 2002 Further information Neil Clark CeNeS Pharmaceuticals plc 01223 266 466...

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next